News headlines claiming breakthroughs in cancer research have become commonplace, and there is no doubt that many new treatments introduced over the past decade have improved survival and quality of life for cancer patients. So much more is needed however. Clinical Trials bridge the gap between the test tube and the clinic, to prove the worth of these new strategies in real people. The Patricia Ritchie Centre for Cancer Care and Research has an active and varied clinical trials program, and we encourage you to ask your Doctor or nurse if one of our studies is an option for you.
Participation in international clinical trials evaluating new drugs for the treatment of cancer may offer our patients access to new therapies not yet available in Australia. In addition we plan and undertake studies aimed to improve quality of life during and following treatment with the goal of improving the experience and outcome for all cancer patients.
Mrs Patricia Ritchie held the strong belief that the key to successful treatment is clinical research. Sharing the knowledge gained with others will advance the care of cancer patients worldwide.
Our clinical trials staff work along with your oncologist and nurses to support you during your treatment. They are available to assist you with treatment planning and follow up as well as collecting vital data during your trial participation. All our research studies have been approved by the Research Ethics Committee of St Vincent’s Health Australia, Sydney and will safeguard your privacy and safety at all times.
Further Information on clinical trials
Visit the Australian Cancer Trials website
Clinical Trials Open Now
The purpose of this study is to find out if women with hormone –receptor- positive (ER+) breast cancer benefit when the experimental drug Palbociclib is added to standard adjuvant hormone treatment. All patients who are invited to take part in this study will have already received neoadjuvant chemotherapy followed by surgery.
For further information: https://www.bcia.org.au/clinical-trials/anz1402/penelope-b
For women recently diagnosed with hormone –receptor- positive (ER+) breast cancer and your doctor is considering treatment prior to surgery, known as neoadjuvant chemotherapy. The purpose of this research is to test whether giving 2 types of breast cancer treatment at the same time is more effective than giving them one after the other. These treatments, chemotherapy and hormone treatment, are usually given one after the other. For further information: https://www.bcia.org.au/clinical-trials/anz1401/eliminate
KEYNOTE – 086
Oncology immunotherapy is a kind of cancer treatment designed to work with the body's natural defenses to fight the cancer. Pembrolizumab is a drug that has been approved for use in Australia for the treatment of advanced melanoma in adults. It is now being tested for women with breast cancer called metastatic triple-negative breast cancer (mTNBC).
For further information on this trial please discuss with your treating clinician.
The purpose of the study is to determine if some women with early breast cancer can avoid radiotherapy treatment after breast surgery.
For further information: https://www.anzbctg.org/clinical-trials/anz1002/prospect
This study looks at the effectiveness and safety of treatment with the herb Ginkgo Biloba in preventing or reducing changes in thinking, memory and concentration (cognitive function) experienced by some women during and after treatment with chemotherapy for early breast cancer. This study is suitable for women who are diagnosed with breast cancer, who have not yet started chemotherapy.
For further information: Corrinne Renton at email@example.com
For Further Information on clinical trials
Visit the Australia & New Zealand Breast Cancer Trials Group
Or Download the ClinTrial Refer Oncology NSW App. (Available on iTunes or Android.)